DE60144338D1 - Gen-abgabeformulierungen zur behandlung ischämischer zustände - Google Patents

Gen-abgabeformulierungen zur behandlung ischämischer zustände

Info

Publication number: DE60144338D1
Authority: DE; Germany
Prior art keywords: geneform; formulations; treatment; delivery; ischemic conditions
Prior art date: 2000-10-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE60144338T

Other languages

English (en)

Inventor

Michael E Coleman

Fiona Maclaughlin

Jijun Wang

Mary L Thiesse

Stewart Young

Jeffrey L Nordstrom

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Fresh Tracks Therapeutics Inc

Original Assignee

Vical Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-20

Filing date

2001-10-19

Publication date

2011-05-12

2001-10-19 Application filed by Vical Inc filed Critical Vical Inc

2011-05-12 Application granted granted Critical

2011-05-12 Publication of DE60144338D1 publication Critical patent/DE60144338D1/de

2021-10-20 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Zoology (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Vascular Medicine (AREA)
General Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Immunology (AREA)
Plant Pathology (AREA)
Toxicology (AREA)
Physics & Mathematics (AREA)
Microbiology (AREA)
Urology & Nephrology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicinal Preparation (AREA)

DE60144338T 2000-10-20 2001-10-19 Gen-abgabeformulierungen zur behandlung ischämischer zustände Expired - Lifetime DE60144338D1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US24227700P	2000-10-20	2000-10-20
US29445401P	2001-05-29	2001-05-29
PCT/US2001/051307 WO2002061040A2 (en)	2000-10-20	2001-10-19	Gene delivery formulations and methods for treatment of ischemic conditions

Publications (1)

Publication Number	Publication Date
DE60144338D1 true DE60144338D1 (de)	2011-05-12

Family

ID=26934967

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE60144338T Expired - Lifetime DE60144338D1 (de)	2000-10-20	2001-10-19	Gen-abgabeformulierungen zur behandlung ischämischer zustände

Country Status (7)

Country	Link
EP (1)	EP1337242B1 (de)
JP (1)	JP2004518693A (de)
CN (1)	CN1531422A (de)
AT (1)	ATE503463T1 (de)
CA (1)	CA2426582A1 (de)
DE (1)	DE60144338D1 (de)
WO (1)	WO2002061040A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2835749B1 (fr)	2002-02-08	2006-04-14	Inst Nat Sante Rech Med	Composition pharmaceutique ameliorant le transfert de gene in vivo
WO2007100776A2 (en)	2006-02-28	2007-09-07	Becton, Dickinson And Company	Antimicrobial compositions and methods for locking catheters
US20140378659A1 (en) *	2012-02-10	2014-12-25	National Cerebral And Cardiovascular Center	Oxidized ldl inhibitor
EP2960252A1 (de) *	2014-06-26	2015-12-30	Institut Pasteur	Phospholipase zur Behandlung von Immunosuppression

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0576612T3 (da) *	1991-03-19	2000-05-22	Cytrx Corp	Polyoxypropylen/polyoxyethylen-copolymerer med forbedret aktivitet
US5616487A (en) *	1994-09-15	1997-04-01	Aastrom Biosciences, Inc.	Stabilized retrovirus compositions
US6359054B1 (en) *	1994-11-18	2002-03-19	Supratek Pharma Inc.	Polynucleotide compositions for intramuscular administration
US6040295A (en) *	1995-01-13	2000-03-21	Genemedicine, Inc.	Formulated nucleic acid compositions and methods of administering the same for gene therapy
US5874562A (en) *	1995-06-07	1999-02-23	Progenitor, Inc.	Nucleic acid encoding developmentally-regulated endothelial cell locus-1
US6080728A (en) *	1996-07-16	2000-06-27	Mixson; A. James	Carrier: DNA complexes containing DNA encoding anti-angiogenic peptides and their use in gene therapy
US5945100A (en) *	1996-07-31	1999-08-31	Fbp Corporation	Tumor delivery vehicles
FR2759298B1 (fr) *	1997-02-10	1999-04-09	Rhone Poulenc Rorer Sa	Formulation de particules agent(s) de transfection cationique(s)/acides nucleiques stabilisees
CA2337496A1 (en) *	1998-07-27	2000-02-10	Valentis, Inc.	Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same
DE69931166T2 (de) *	1998-08-14	2007-02-15	Valentis Inc., Burlingame	Co-lyophilisierter komplex umfassend einen nukleinsäurevektor und ein formulierungsagens
WO2001065911A2 (en) *	2000-03-03	2001-09-13	Valentis, Inc.	Improved poloxamer and poloxamine compositions for nucleic acid delivery

2001
- 2001-10-19 WO PCT/US2001/051307 patent/WO2002061040A2/en active Application Filing
- 2001-10-19 JP JP2002561597A patent/JP2004518693A/ja active Pending
- 2001-10-19 DE DE60144338T patent/DE60144338D1/de not_active Expired - Lifetime
- 2001-10-19 AT AT01999202T patent/ATE503463T1/de not_active IP Right Cessation
- 2001-10-19 CA CA002426582A patent/CA2426582A1/en not_active Abandoned
- 2001-10-19 CN CNA018206557A patent/CN1531422A/zh active Pending
- 2001-10-19 EP EP01999202A patent/EP1337242B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
WO2002061040A3 (en)	2003-02-27
ATE503463T1 (de)	2011-04-15
EP1337242A4 (de)	2005-12-07
WO2002061040A2 (en)	2002-08-08
CA2426582A1 (en)	2002-08-08
EP1337242B1 (de)	2011-03-30
EP1337242A2 (de)	2003-08-27
JP2004518693A (ja)	2004-06-24
CN1531422A (zh)	2004-09-22

Publication	Publication Date	Title
ATE286761T1 (de)	2005-01-15	Vorrichtungen zum verschliessen der aufsteigenden aorta eines patienten
DK1267897T3 (da)	2005-02-14	Behandling af kongestiv hjerteinsuffiens med forbehandlet autologt blod
CY1109191T1 (el)	2014-07-02	Μια νεα χρηση της δεφεριπρονης
ES2136618T3 (es)	1999-12-01	Cicatrizacion de heridas.
SE9702860D0 (sv)	1997-08-05	New use
ATE400314T1 (de)	2008-07-15	Katheterschaft mit mehreren leitungen zur verminderung von gliedischämie
HK1046096A1 (en)	2002-12-27	Solutions and methods for inhibitions of pain, inflammation and cartilage degradation
ATE241378T1 (de)	2003-06-15	Kombinationen von vasopressin und adrenergischen wirkstoffen zur behandlung des plötzlichen herztods
ATE317693T1 (de)	2006-03-15	Substituierte stilbene mit gefässschädigender aktivität
PT1196185E (pt)	2005-07-29	Nova utilizacao de solucoes salinas hipo-osmoticas e medicamento a base de tais solucoes
DE60144338D1 (de)	2011-05-12	Gen-abgabeformulierungen zur behandlung ischämischer zustände
SE9900043D0 (sv)	1999-01-11	New use
DE60139009D1 (de)	2009-07-30	Herzunterstützungsvorrichtung
ATE359798T1 (de)	2007-05-15	Verwendungvon dextransulfat zur behandlung von ibmir
SE9101840L (sv)	1992-12-15	Ny medicinsk anvaendning
ES2055680T3 (es)	1996-01-01	Fijador y procedimiento para el moldeado permanente del cabello.
ATE241971T1 (de)	2003-06-15	Kombinationspräparat zur behandlung von malaria
El-Kashef et al.	1999	Low level laser therapy in the treatment of arteriosclerosis of the lower limbs
MXPA03001812A (es)	2004-05-21	Modulacion de la expresion del sindrome de alcohol fetal y del ligando del sindrome de alcohol fetal..
BR0301056A (pt)	2005-05-10	Tratamento de varizes
RU97110054A (ru)	1999-06-10	Способ лечения синдрома "диабетическая стопа"